B Reed

Summary

Affiliation: The Rockefeller University
Country: USA

Publications

  1. ncbi Dual-electrode voltammetry of catecholamine transport: simultaneous monitoring of uptake and efflux
    Brian Reed
    Department of Chemistry, Emory University, Atlanta, GA, USA
    J Neurosci Methods 126:127-35. 2003
  2. ncbi Dynorphin A(1-17) biotransformation in striatum of freely moving rats using microdialysis and matrix-assisted laser desorption/ionization mass spectrometry
    Brian Reed
    Laboratory of the Biology of Addictive Diseases, The Rockefeller University, New York, New York, USA
    J Neurochem 86:815-23. 2003
  3. ncbi Extracellular biotransformation of beta-endorphin in rat striatum and cerebrospinal fluid
    B Reed
    Laboratory of the Biology of Addictive Diseases, The Rockefeller University, New York, NY 10021, USA
    J Neuroendocrinol 20:606-16. 2008
  4. ncbi Carbon dioxide-induced anesthesia results in a rapid increase in plasma levels of vasopressin
    Brian Reed
    Laboratories of the Biology of Addictive Diseases, Gaseous Ion Chemistry and MassSpectrometry, The Rockefeller University, New York, New York 10065, USA
    Endocrinology 150:2934-9. 2009
  5. ncbi Limited effects of beta-endorphin compared to loperamide or fentanyl in a neuroendocrine biomarker assay in non-human primates
    Eduardo R Butelman
    Laboratory on the Biology of Addictive Diseases, The Rockefeller University, 1230 York Avenue, New York, NY 10065, USA
    Psychoneuroendocrinology 33:292-304. 2008
  6. ncbi Bidirectional translational research: Progress in understanding addictive diseases
    M J Kreek
    Laboratory of the Biology of Addictive Diseases, Rockefeller University, 1230 York Avenue, New York, NY 10065, USA
    Neuropharmacology 56:32-43. 2009
  7. ncbi Differential glutamate AMPA-receptor plasticity in subpopulations of VTA neurons in the presence or absence of residual cocaine: Implications for the development of addiction
    D A Lane
    Department of Neurology and Neuroscience, Weill Medical College of Cornell University, New York, NY 10065, USA
    Neuropharmacology 61:1129-40. 2011
  8. ncbi Affinity labeling the dopamine transporter ligand binding site
    Roxanne A Vaughan
    Department of Biochemistry and Molecular Biology, University of North Dakota, School of Medicine and Health Sciences, 501 N Columbia Road, Grand Forks, ND 58203, USA
    J Neurosci Methods 143:33-40. 2005

Detail Information

Publications8

  1. ncbi Dual-electrode voltammetry of catecholamine transport: simultaneous monitoring of uptake and efflux
    Brian Reed
    Department of Chemistry, Emory University, Atlanta, GA, USA
    J Neurosci Methods 126:127-35. 2003
    ....
  2. ncbi Dynorphin A(1-17) biotransformation in striatum of freely moving rats using microdialysis and matrix-assisted laser desorption/ionization mass spectrometry
    Brian Reed
    Laboratory of the Biology of Addictive Diseases, The Rockefeller University, New York, New York, USA
    J Neurochem 86:815-23. 2003
    ..Additional modifications, of mass 42 and 113 Da, were also found on the N-terminus (Ile8 or Pro10) of these same C-terminal fragments. The role of these modifications of C-terminal fragments has not yet been characterized...
  3. ncbi Extracellular biotransformation of beta-endorphin in rat striatum and cerebrospinal fluid
    B Reed
    Laboratory of the Biology of Addictive Diseases, The Rockefeller University, New York, NY 10021, USA
    J Neuroendocrinol 20:606-16. 2008
    ....
  4. ncbi Carbon dioxide-induced anesthesia results in a rapid increase in plasma levels of vasopressin
    Brian Reed
    Laboratories of the Biology of Addictive Diseases, Gaseous Ion Chemistry and MassSpectrometry, The Rockefeller University, New York, New York 10065, USA
    Endocrinology 150:2934-9. 2009
    ....
  5. ncbi Limited effects of beta-endorphin compared to loperamide or fentanyl in a neuroendocrine biomarker assay in non-human primates
    Eduardo R Butelman
    Laboratory on the Biology of Addictive Diseases, The Rockefeller University, 1230 York Avenue, New York, NY 10065, USA
    Psychoneuroendocrinology 33:292-304. 2008
    ..v. administration. Thus, the relative ineffectiveness of i.v. beta-endorphin in this assay does not appear to be principally due to rapid generation of non-opioid fragments of this neuropeptide...
  6. ncbi Bidirectional translational research: Progress in understanding addictive diseases
    M J Kreek
    Laboratory of the Biology of Addictive Diseases, Rockefeller University, 1230 York Avenue, New York, NY 10065, USA
    Neuropharmacology 56:32-43. 2009
    ....
  7. ncbi Differential glutamate AMPA-receptor plasticity in subpopulations of VTA neurons in the presence or absence of residual cocaine: Implications for the development of addiction
    D A Lane
    Department of Neurology and Neuroscience, Weill Medical College of Cornell University, New York, NY 10065, USA
    Neuropharmacology 61:1129-40. 2011
    ....
  8. ncbi Affinity labeling the dopamine transporter ligand binding site
    Roxanne A Vaughan
    Department of Biochemistry and Molecular Biology, University of North Dakota, School of Medicine and Health Sciences, 501 N Columbia Road, Grand Forks, ND 58203, USA
    J Neurosci Methods 143:33-40. 2005
    ..Using these methods we have identified two distinct regions of DAT that interact with multiple structurally related and diverse irreversible ligands, suggesting that these regions may be involved in the formation of ligand binding sites...